Second, concerning high AD prevalence in females, it is recommended to highlight the probable role of gender differences or interference in various behavior assessments or molecular indicators in clinical or non-clinical studies in order to find more meticulous findings underlying the complicated effects of APOE genotype. This evidence concerns the gene APOE and Alzheimer disease.